1 Min Read
Feb 21 (Reuters) - Amgen Inc:
* Repatha (evolocumab) receives european commission approval for new 420 mg single-dose delivery option Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.